Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cord Blood Eye Drops in Neurotrophic Keratopathy
NCT03084861Phase 2Terminated
- Sponsor
- Banc de Sang i Teixits
- Start
- Feb 2017
- Primary completion
- Mar 2020
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of human umbilical cord blood plasma in neurotrophic keratopathy (NK) (2 arms), sponsored by Banc de Sang i Teixits. Primary endpoint: Corneal lesion size. Started Feb 2017; status: terminated.
02
Drugs
human umbilical cord blood plasma
03
Conditions
neurotrophic keratopathy (NK)
Beyond the preview
Go deeper on NCT03084861.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03084861.